ProShare Advisors’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $555K | Buy |
7,390
+236
| +3% | +$18.6K | ﹤0.01% | 1004 |
|
|
2025
Q4 | $566K | Buy |
7,154
+1,476
| +26% | +$111K | ﹤0.01% | 1066 |
|
|
2025
Q3 | $371K | Sell |
5,678
-265
| -4% | -$12.9K | ﹤0.01% | 1283 |
|
|
2025
Q2 | $235K | Sell |
5,943
-1,228
| -17% | -$40.2K | ﹤0.01% | 1614 |
|
|
2025
Q1 | $216K | Sell |
7,171
-309
| -4% | -$10.1K | ﹤0.01% | 1640 |
|
|
2024
Q4 | $262K | Sell |
7,480
-1,160
| -13% | -$43.4K | ﹤0.01% | 1740 |
|
|
2024
Q3 | $346K | Sell |
8,640
-371
| -4% | -$17.3K | ﹤0.01% | 1367 |
|
|
2024
Q2 | $429K | Sell |
9,011
-1,205
| -12% | -$49.4K | ﹤0.01% | 1057 |
|
|
2024
Q1 | $443K | Buy |
10,216
+1,049
| +11% | +$50K | ﹤0.01% | 1162 |
|
|
2023
Q4 | $464K | Sell |
9,167
-203
| -2% | -$9.72K | ﹤0.01% | 1081 |
|
|
2023
Q3 | $425K | Buy |
9,370
+112
| +1% | +$4.62K | ﹤0.01% | 994 |
|
|
2023
Q2 | $380K | Sell |
9,258
-653
| -7% | -$25.1K | ﹤0.01% | 1120 |
|
|
2023
Q1 | $354K | Sell |
9,911
-3,992
| -29% | -$150K | ﹤0.01% | 1105 |
|
|
2022
Q4 | $525K | Sell |
13,903
-295
| -2% | -$12.4K | ﹤0.01% | 943 |
|
|
2022
Q3 | $628K | Buy |
14,198
+831
| +6% | +$35K | ﹤0.01% | 833 |
|
|
2022
Q2 | $495K | Sell |
13,367
-4,534
| -25% | -$171K | ﹤0.01% | 939 |
|
|
2022
Q1 | $663K | Sell |
17,901
-5,531
| -24% | -$181K | ﹤0.01% | 1112 |
|
|
2021
Q4 | $713K | Sell |
23,432
-10,067
| -30% | -$317K | ﹤0.01% | 1224 |
|
|
2021
Q3 | $1.12M | Buy |
33,499
+3,076
| +10% | +$116K | ﹤0.01% | 862 |
|
|
2021
Q2 | $1.21M | Buy |
30,423
+8,288
| +37% | +$325K | ﹤0.01% | 926 |
|
|
2021
Q1 | $995K | Sell |
22,135
-1,955
| -8% | -$109K | ﹤0.01% | 985 |
|
|
2020
Q4 | $1.36M | Sell |
24,090
-839
| -3% | -$41.8K | 0.01% | 756 |
|
|
2020
Q3 | $1.18M | Buy |
24,929
+620
| +3% | +$34.4K | 0.01% | 679 |
|
|
2020
Q2 | $1.43M | Buy |
24,309
+2,602
| +12% | +$145K | 0.01% | 621 |
|
|
2020
Q1 | $1.03M | Sell |
21,707
-11,769
| -35% | -$656K | 0.01% | 593 |
|
|
2019
Q4 | $2.02M | Sell |
33,476
-7,564
| -18% | -$451K | 0.01% | 621 |
|
|
2019
Q3 | $2.46M | Sell |
41,040
-3,341
| -8% | -$218K | 0.01% | 549 |
|
|
2019
Q2 | $2.85M | Sell |
44,381
-7,907
| -15% | -$559K | 0.02% | 517 |
|
|
2019
Q1 | $4.24M | Buy |
52,288
+1,613
| +3% | +$104K | 0.03% | 447 |
|
|
2018
Q4 | $2.74M | Sell |
50,675
-10,154
| -17% | -$518K | 0.02% | 511 |
|
|
2018
Q3 | $3.14M | Buy |
60,829
+5,086
| +9% | +$239K | 0.02% | 523 |
|
|
2018
Q2 | $2.32M | Sell |
55,743
-5,436
| -9% | -$241K | 0.02% | 588 |
|
|
2018
Q1 | $2.7M | Sell |
61,179
-9,419
| -13% | -$479K | 0.02% | 559 |
|
|
2017
Q4 | $3.55M | Sell |
70,598
-2,407
| -3% | -$132K | 0.02% | 500 |
|
|
2017
Q3 | $3.7M | Buy |
73,005
+6,775
| +10% | +$355K | 0.03% | 434 |
|
|
2017
Q2 | $3.37M | Sell |
66,230
-1,039
| -2% | -$48.4K | 0.03% | 445 |
|
|
2017
Q1 | $2.7M | Sell |
67,269
-14,539
| -18% | -$653K | 0.03% | 474 |
|
|
2016
Q4 | $3.91M | Buy |
81,808
+2,221
| +3% | +$87.9K | 0.04% | 383 |
|
|
2016
Q3 | $2.92M | Sell |
79,587
-14,326
| -15% | -$448K | 0.04% | 386 |
|
|
2016
Q2 | $2.19M | Buy |
93,913
+1,997
| +2% | +$64.4K | 0.03% | 473 |
|
|
2016
Q1 | $3.72M | Sell |
91,916
-9,179
| -9% | -$373K | 0.05% | 300 |
|
|
2015
Q4 | $6.26M | Buy |
101,095
+5,208
| +5% | +$281K | 0.08% | 254 |
|
|
2015
Q3 | $3.88M | Sell |
95,887
-6,291
| -6% | -$326K | 0.05% | 316 |
|
|
2015
Q2 | $5.88M | Sell |
102,178
-21,857
| -18% | -$1.39M | 0.08% | 243 |
|
|
2015
Q1 | $7.9M | Buy |
124,035
+14,495
| +13% | +$983K | 0.09% | 222 |
|
|
2014
Q4 | $6.76M | Sell |
109,540
-1,589
| -1% | -$78.4K | 0.08% | 262 |
|
|
2014
Q3 | $4.32M | Sell |
111,129
-22,086
| -17% | -$783K | 0.06% | 327 |
|
|
2014
Q2 | $4.59M | Sell |
133,215
-73,546
| -36% | -$2.32M | 0.06% | 327 |
|
|
2014
Q1 | $8.93M | Buy |
206,761
+143,767
| +228% | +$6.97M | 0.11% | 155 |
|
|
2013
Q4 | $2.51M | Sell |
62,994
-51,471
| -45% | -$1.83M | 0.04% | 626 |
|
|
2013
Q3 | $4.3M | Buy |
114,465
+17,563
| +18% | +$525K | 0.1% | 161 |
|
|
2013
Q2 | $2.6M | Buy |
+96,902
| New | +$2.06M | 0.05% | 361 |
|
Other funds holding IONS
VPM
VCM
ProShare Advisors's IONS Position: Q1 2026 in Review
ProShare Advisors increased its Ionis Pharmaceuticals (IONS) stake by 3.3% in Q1 2026, buying an estimated $18.6K and bringing the position to 7,390 shares worth $555K. The position accounts for ﹤0.01% of the portfolio, ranked #1004.
ProShare Advisors first reported a position in IONS in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.93M in Q1 2014. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.
- ProShare Advisors held 7,390 shares of Ionis Pharmaceuticals worth $555K as of Q1 2026.
- ProShare Advisors bought 236 Ionis Pharmaceuticals shares in Q1 2026, an estimated $18.6K.
- Ionis Pharmaceuticals made up ﹤0.01% of ProShare Advisors's portfolio in Q1 2026, its #1004 holding.
- ProShare Advisors first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- ProShare Advisors's Ionis Pharmaceuticals position peaked at $8.93M in Q1 2014.
- 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.
Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.